elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40362365-29496FE1-608F-44C0-98CE-5E5B8D55C902
Q40362365-29496FE1-608F-44C0-98CE-5E5B8D55C902
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40362365-29496FE1-608F-44C0-98CE-5E5B8D55C902
Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.
P2860
Q40362365-29496FE1-608F-44C0-98CE-5E5B8D55C902
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40362365-29496FE1-608F-44C0-98CE-5E5B8D55C902
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c409cd3faeafceea26e5aba14a4f974e7d9d3ce7
P2860
A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.